The global non-surgical rhinoplasty market is expected to register significant growth in the forecast period. Non-Surgical Rhinoplasty, also known as liquid Rhinoplasty is a minimally invasive cosmetic procedure that allows alterations and treating deformities of the nose. Usually, an invasive rhinoplasty involves making incisions on the nose altering its structure which can be costly and have a high downtime. Factors like rising demand for minimally invasive cosmetic treatments, increasing use of dermal fillers for aesthetic modifications, increasing pool of cosmetic professionals and high social media influence is expected to significantly boost the market growth.
HA is the most common filler of choice for 80% of nonsurgical rhinoplasty procedures and is preferred by clinicians due to its softness and natural feel. It also dissolves quickly and is reversible with minimal side effects. As per Plastic and Aesthetic Research, the use of soft tissue filler is the second most common minimally invasive cosmetic procedure in 2020 in the U.S. The major factor restraining the market involves the potential for serious complications like tissue necrosis and blindness as well as repeated sessions of the injections as the results from the fillers last for a few months which might hinder the market growth.
The asymmetry application segment is expected to account for the highest market share to bring uniformity in the appearance of the nose and give it a more proportionate appearance in comparison to the face. Based on filler type the Hyaluronic Acid Filler segment held the largest market share as the filler is biocompatible and delivers effective results in contouring the shape of the nose.
The Non-Surgical Rhinoplasty market faced a significant setback in the initial quarters of 2020 due to COVID-19. However, the onset of COVID-19 acted as a springboard for non-invasive aesthetic treatments as the market witnessed higher demand for treatments like fillers, botox, and skin lasers to look appealing on zoom calls and meetings. As per Bloomberg treatments like soft tissue fillers and neurotoxin injectables, remained the most popular minimally invasive procedures in the U.S in 2020.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."